Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 470-720-1 | CAS number: 189253-72-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2005
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- GLP compliance:
- yes
- Remarks:
- statement
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- -
- EC Number:
- 470-720-1
- EC Name:
- -
- Cas Number:
- 189253-72-3
- Molecular formula:
- C10H25N3O
- IUPAC Name:
- N-(2-(dimethylamino)ethoxy)ethyl)-N-methyl-1,3-propanediamine
- Details on test material:
- N-(2-[2-(dimethylamine)ethoxy]ethyl)-N-methyl-1,3-propanediamine
Batch 19902-1
Purity >92%
Expiry date 31 October 2006
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Animals were housed in a controlled environment, in which optimal conditions were considered
to be approximately 15 air changes per hour, a temperature of 21.0 + 3.0•‹C (actual range: 19.7 -
21.7"C), a relative humidity of 30-70% (actual range: 43 - 69%) and 12 hours art'rficial
fluorescent light and 12 hours darkness per day.
Accommodation
Group housing of 3 animals per sex per cage in labelled Macrolon cages (type IV; height 18
cm.) containing sterilised sawdust as bedding material (Woody-Clean type 314; Tecnilab-BMI
BV, Someren, The Netherlands) and paper as cage-enrichment (Envirodri, BMI, Helmond, The
Netherlands).
Acclimatisation period was at least 5 days before start of treatment under laboratory conditions.
Diet
Free access to standard pelleted laboratory animal diet (from Altromin (code VRF l), Lage,
Germany).
Water
Free access to tap water.
Certificates of analysis for ingredients and/or contaminants of diet, sawdust, paper and water
were examined and then retained in the NOTOX archives.
Results of analysis for ingredients and/or contaminants of diet, sawdust, paper, and water were
assessed and did not reveal any findings that were considered to have affected study integrity.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- The vehicle (water) was selected based on trial formulations performed at NOTOX.
The formulations (wlw) were prepared within 4 hours prior to dosing. Homogeneity was accomplished to a visually acceptable level. Adjustment was made for the density of the test substance. The concentration of the test substance in vehicle was varied to allow constant dosage volume in terms of ml/kg body weight. - Doses:
- 300 mg/kg body weight, 2000 mg/kg body weight
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- The toxicity of the test substance was assessed by stepwise treatment of groups of 3 females. The first group was treated at a dose level of 300 mglkg. The absence or presence of mortality of animals dosed at one step determined the next step, based on the test procedure defined in the guidelinesThe onset, duration and severity of the signs of toxicity were taken into account for determination of the time interval between the dose groups.
- Statistics:
- No statistical analysis was performed (The method used is not intended to allow the calculation of a precise LD9 value).
Results and discussion
- Preliminary study:
- No preliminary study was performed.
Effect levelsopen allclose all
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 300 - < 2 000 mg/kg bw
- Based on:
- test mat.
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 1 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- Two females dosed at 2000 mg/kg were found dead on days 2 or 4. No further mortality occurred.
- Clinical signs:
- 2000 mglkg - Lethargy, hunched posture, uncoordinated movements, ptosis, piloerection, chromodacryorrhoea
300 mglkg - Hunched posture and uncoordinated movements - Body weight:
- The body weight gain shown by the surviving animals over the study period was considered to be similar to that expected of normal untreated animals of the same age and strain.
- Other findings:
- Macroscopic Finding
Macroscopic examination revealed abnormalities in the stomach (dark red discoloration, thickening of the glandular mucosa, irregular surface of the glandular mucosa) among the animals that died (2000 mg/kg). No abnormalities were found at macroscopic post mortem examination of the
surviving animals.
Applicant's summary and conclusion
- Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information LD50 > 300 and < 2000mg/kg b.w. Criteria used for interpretation of results: EU
- Conclusions:
- The oral LD50 value of N-{2-[2-(Dimethylamine)Ethoxy]Ethyl)-N-Methyl-1,3-Propanediamine in Wistar rats was established to be within the range of 300-2000 mg/kg body weight. The LD50 cutoff point is 1000 mg/kg b.w.
- Executive summary:
The oral LD50 value of N-{2-[2-(Dimethylamine)Ethoxy]Ethyl)-N-Methyl-1,3-Propanediamine in Wistar rats was established to be within the range of 300-2000 mg/kg body weight.
According to the OECD 423 test guideline the LD50 cut-off value was considered to be 1000 mg/kg body weight.
Initially, N- (2-[2-(Dimethylamine)Ethoxy]Ethyl ) -N-Methyl- l,3-Propanediamine was administered by oral
gavage to three female Wistar rats at 300 mgkg body weight. In a stepwise procedure additional groups of
females were dosed at 300 and 2000 m a g body weight. All animals were subjected to daily observations
and weekly determination of body weight. Macroscopic examination was performed on the day of death or
after terminal sacrifice (day 15 j.
Two females dosed at 2000 mgkg were found dead on days 2 or 4. No further mortality occurred.
The surviving animals had recovered from the symptoms between days 3 and 7.
Clinical signs : Lethargy, hunched posture, uncoordinated movements, ptosis, piloerection,
chromodacrvorrhoea
The body weight gain shown by the surviving animals over the study period was considered to be normal.
Macroscopic examination revealed abnormalities in the stomach (dark red discoloration, thickening of the
glandular mucosa, irregular surface of the glandular mucosa) among the animals that died (2000 mgkgj. No
abnormalities were found at macroscopic post mortem examination of the surviving animals.
The oral LD50 value of N32-[2-(D1METHYLAMINE)ETHOXflETHYL)-N-METHYL- ,3-PROPANEDIAMINE in Wistar rats was established to be within the range of 300-2000 mg/kg body weight. The LD 50 cuoff point is 1000 mg/kg b.w.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.